SPRINGFIELD, Ill. – Health insurance providers will be required to cover medication that slows the progression of Alzheimer’s Disease and other related dementias under a new law backed by state Rep. Dave Vella, D-Rockford.
“This is a proposal led by the Alzheimer’s Association and impacted families that will help more people access the healthcare they deserve,” Vella said. “When it comes to Alzheimer’s and similar dementias, every single moment matters. With this law, Illinois is becoming a national leader on this subject, eliminating barriers and insurance gimmicks that could cause unnecessary delays and interfere with the wellbeing of patients.”
Vella sponsored and supported Senate Bill 126, which requires health insurance providers to cover medication that slows the progression of Alzheimer’s Disease and other related dementias. Such coverage includes all medically necessary diagnostic testing and medication approved by the U.S. Food and Drug Administration. Insurance providers would be prohibited from utilizing “step therapy,” a strategy that involves using different, less costly treatments requiring patients to “fail first” before receiving what was prescribed.
The measure’s requirements would apply to private health insurance plans regulated by the state, self- insuring counties, self-insuring municipalities, self-insuring school districts, Health Maintenance Organizations (HMOs) and Limited Health Service Organizations. HMOs under contract with the Department of Healthcare and Family Services are exempt.
“There are promising treatments in development and coming to market that could make a difference in the lives of many, but administration in the early stages of the disease is critical for effectiveness,” Vella said. “I’m glad Illinois is looking ahead with this law, and I hope other states soon join us.”
Senate Bill 126 received bipartisan support, and was signed into law by the governor this month.
For more information, please contact RepDaveVella@gmail.com.